Nonalcoholic Steatohepatitis: A Search for Factual Animal Models
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, which occurs in the absence of alcohol abuse. NAFLD can evolve into progressive liver injury and fibrosis in the form of nonalcoholic steatohepatitis (NASH). Several animal models have been developed to attempt to represent the morphological, biochemical, and clinical features of human NASH. The actual review presents a critical analysis of the most commonly used experimental models of NAFLD/NASH development. These models can be classified into genetic, nutritional, and a combination of genetic and nutritional factors. The main genetic models are ob/ob and db/db mutant mice and Zucker rats. The principal nutritional models employ methionine- and choline-deficient, high-fat, high-cholesterol and high-cholate, cafeteria, and high-fructose diets. Currently, associations between high-fructose and various compositions of high-fat diets have been widely studied. Previous studies have encountered significant difficulties in developing animal models capable of reproducing human NASH. Some models produce consistent morphological findings, but the induction method differs significantly compared with the pathophysiology of human NASH. Other models precisely represent the clinical and etiological contexts of this disease but fail to provide accurate histopathological representations mainly in the progression from steatosis to liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 The main mechanisms involved in the pathophysiology of the nonalcoholic steatohepatitis (NASH). FFA: free fatty acids; ROS: reactive oxygen species; TG: triglycerides (adapted from Angulo, 2002 [8]).](https://figures.cochat.ai/paper-figures/b42710eb3879438e98ec968c00dfef0a/nonalcoholic-steatohepatitis-a-search-for-factual-animal-models-figure-2.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The relevance of these models to humans is questionable because they most often essentialize isolated aspects of the human pathophysiology (6).”
From Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis (2016) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077 · cited 1×
“Probably, lipid accumulation occurs in parallel with the generation of lipotoxic metabolites, which are primarily responsible for the progression of liver disease [19, 23].”
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955 · cited 1×
“In hepatic steatosis, the imbalance between scarce endogenous antioxidant reserves and augmented mitochondrial production of free radicals results in oxidative damage to lipids, proteins, and DNA with subsequent cell death [9, 10].”
Bedossa, P., Poitou, C., Veyrie, N., Bouillot, J.-L., Basdevant, A., Paradis, V., Tordjman, J., & Clement, K. (2012) · Hepatology · doi:10.1002/hep.25889 · Cited by 903 · cited 1×
“Another similar method for NASH grading is the SAF system, which comprises a semiquantitative score of steatosis (S), inflammatory activity (A), and fibrosis (F) [7].”
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863 · cited 1×
“In humans, increased levels of fructose consumption, primarily in the form of corn syrup for soft drinks, are associated with increased severity of hepatic steatosis and fibrosis [60, 61].”
Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., & Brown, M. S. (1998) · Genes & Development · doi:10.1101/gad.12.20.3182 · Cited by 790 · cited 1×
“Similar to some forms of congenital lipodystrophies, the amount of systemic fat tissue is decreased, but the animals present significant hepatic lipid accumulation [27].”
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771 · cited 1×
“No published data on animals demonstrated that administration of fructose alone can alter themetabolic parameters associatedwithNASH, but fructose has been reported to alter potent biochemical properties involved in promoting insulin resistance [66].”
Abdelmalek, M. F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R. J., & Diehl, A. M. (2010) · Hepatology · doi:10.1002/hep.23535 · Cited by 770
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.018 · Cited by 759 · cited 1×
“Both JNK and p38 MAP kinase are involved inmechanisms of apoptosis [17, 18].”
Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research
Anstee, Q. M., & Goldin, R. D. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2006.00465.x · Cited by 714
Sampey, B. P., Vanhoose, A. M., Winfield, H. M., Freemerman, A. J., Muehlbauer, M. J., Fueger, P. T., Newgard, C. B., & Makowski, L. (2011) · Obesity · doi:10.1038/oby.2011.18 · Cited by 617 · cited 2×
“This diet induced panlobular microvesicular steatosis, steatohepatitis, and chronic inflammation in white and brown adipose tissues [56].”
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Marí, M., Caballero, F., Colell, A., Morales, A., Caballeria, J., Fernandez, A., Enrich, C., Fernandez-Checa, J. C., & García-Ruiz, C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.07.006 · Cited by 608 · cited 1×
“The HChCh diet also stimulates the liver to produce TNF-α, which increases the inflammatory response and causes the progression of NASH [54].”
Toll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice†
Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S. C., & Bergheim, I. (2009) · Hepatology · doi:10.1002/hep.23122 · Cited by 562 · cited 1×
“Mice submitted to an addition of 30% fructose in drinking water presented a fourfold increase in triglyceride levels and a marked increase in body weight along with steatosis after 8 weeks of ingestion [65].”
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Takahashi, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i19.2300 · Cited by 554 · cited 3×
“Furthermore, mutations in the ob gene are not prevalent in obese subjects or patients with NASH, and leptin levels are not well correlated with the development of NAFLD/NASH [30, 35].”
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
Matsuzawa, N., Takamura, T., Kurita, S., Misu, H., Ota, T., Ando, H., Yokoyama, M., Honda, M., Zen, Y., Nakanuma, Y., et al. (2007) · Hepatology · doi:10.1002/hep.21874 · Cited by 515
Animal models of nonalcoholic fatty liver disease
Hebbard, L., & George, J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.191 · Cited by 499 · cited 16×
“However, this model does not mimic the clinical and etiologic factors of NAFLD/NASH because the diet is forcibly administered (CF−).”
InfluentialCharlton, M., Krishnan, A., Viker, K., Sanderson, S., Cazanave, S., McConico, A., Masuoko, H., & Gores, G. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00145.2011 · Cited by 444 · cited 1×
“Thus, a “fast food”-based diet, composed by high saturated fat, highcholesterol, and high-fructose, may simulate with elevated fidelity the features of the human metabolic syndrome and NASH [70].”
Model of nonalcoholic steatohepatitis
Lieber, C. S., Leo, M. A., Mak, K. M., Xu, Y., Cao, Q., Ren, C., Ponomarenko, A., & DeCarli, L. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.502 · Cited by 424 · cited 2×
“inflammation, mild steatosis, and the absence of the fibrosis progression in contrast with human NASH [47].”
Genetic control of de novo lipogenesis: role in diet-induced obesity
Strable, M. S., & Ntambi, J. M. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409231003667500 · Cited by 416 · cited 1×
“A standard diet is sufficient to induce steatosis, lobular and perivenular inflammation, and pericellular fibrosis in these animals after a period of 8 weeks [28, 29].”
Ribeiro, P. S., Cortez-Pinto, H., Solá, S., Castro, R. E., Ramalho, R. M., Baptista, A., Moura, M. C., Camilo, M. E., & Rodrigues, C. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40009.x · Cited by 395
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385 · cited 1×
“Moreover, it has been shown that lipotoxicity leads to cell injury and death, via apoptosis or necrosis, and may constitute an important proinflammatory and profibrogenic stimulus in chronic liver disease [19, 24].”
Tetri, L. H., Basaranoglu, M., Brunt, E. M., Yerian, L. M., & Neuschwander-Tetri, B. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90272.2008 · Cited by 378 · cited 1×
“Although the ALIOS model led to severe steatosis, liver fibrosis was scarce [67].”
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 376 · cited 3×
“Probably, lipid accumulation occurs in parallel with the generation of lipotoxic metabolites, which are primarily responsible for the progression of liver disease [19, 23].”
Kohli, R., Kirby, M., Xanthakos, S. A., Softic, S., Feldstein, A. E., Saxena, V., Tang, P. H., Miles, L., Miles, M. V., Balistreri, W. F., et al. (2010) · Hepatology · doi:10.1002/hep.23797 · Cited by 376
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
Dyson, J. K., Anstee, Q. M., & McPherson, S. (2014) · Frontline Gastroenterology · doi:10.1136/flgastro-2013-100403 · Cited by 357 · cited 1×
“Although the majority of patients can be effectively diagnosed with NAFLD using noninvasive tests, liver biopsy remains the gold standard for the accurate assessment of the graduation of steatosis, necroinflammatory changes, and fibrosis and allows NASH and steatosis to be distinguished [5, 6].”
High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase
Ishimoto, T., Lanaspa, M. A., Rivard, C. J., Roncal-Jimenez, C. A., Orlicky, D. J., Cicerchi, C., McMahan, R. H., Abdelmalek, M. F., Rosen, H. R., Jackman, M. R., et al. (2013) · Hepatology · doi:10.1002/hep.26594 · Cited by 331
Kim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331 · cited 14×
“However, this model does not mimic the clinical and etiologic factors of NAFLD/NASH because the diet is forcibly administered (CF−).”
InfluentialA high‐fat diet leads to the progression of non‐alcoholic fatty liver disease in obese rats
Carmiel-Haggai, M., Cederbaum, A. I., & Nieto, N. (2005) · The FASEB Journal · doi:10.1096/fj.04-2291fje · Cited by 318 · cited 1×
“Oxidative stress markers such as lipid peroxidation and protein carbonyl groups were increased, while the hepatic levels of reduced glutathione and antioxidant enzymes were diminished [40].”
Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive
Wieckowska, A., & Feldstein, A. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091983 · Cited by 300 · cited 1×
“Although the majority of patients can be effectively diagnosed with NAFLD using noninvasive tests, liver biopsy remains the gold standard for the accurate assessment of the graduation of steatosis, necroinflammatory changes, and fibrosis and allows NASH and steatosis to be distinguished [5, 6].”
Sahai, A., Malladi, P., Pan, X., Paul, R., Melin-Aldana, H., Green, R. M., & Whitington, P. F. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00199.2004 · Cited by 290 · cited 1×
“When db/db mice are fed an MCD diet, they can develop significant liver fibrosis in contrast to ob/ob mice [36, 37].”
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis #
Witek, R. P., Stone, C. W., Karaca, G. F., Syn, W.-K., Pereira, T. A., Agboola, K. M., Omenetti, A., Jung, Y., Teaberry, V., Choi, S. S., et al. (2009) · Hepatology · doi:10.1002/hep.23167 · Cited by 253 · cited 1×
“However, diverse evidences show that hepatocellular apoptosis is increased both in animal models [11–13] and in human NASH [14– 16].”
Nonalcoholic Fatty Liver Disease: Pathogenesis and the Role of Antioxidants
Mehta, K., Van Thiel, D. H., Shah, N., & Mobarhan, S. (2002) · Nutrition Reviews · doi:10.1301/002966402320387224 · Cited by 250 · cited 3×
“Hyperinsulinemia intensifies the hepatic synthesis of fatty acids by inducing glycolysis and favors the accumulation of triglycerides within hepatocytes by decreasing the liver ability to reesterify and export triglycerides [8, 9].”
Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
Pasarín, M., La Mura, V., Gracia-Sancho, J., García-Calderó, H., Rodríguez-Vilarrupla, A., García-Pagán, J. C., Bosch, J., & Abraldes, J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032785 · Cited by 247 · cited 1×
“The animals presented consistent features of metabolic syndrome such as overweight, arterial hypertension, hypertriglyceridemia, hyperglycemia, insulin resistance, and liver steatosis but did not present significant liver inflammation or fibrosis [59].”
George, J., Pera, N., Phung, N., Leclercq, I., Yun Hou, J., & Farrell, G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00376-3 · Cited by 247 · cited 1×
“Other discrepancies in the metabolic profile of the MCD diet are reduced levels of insulin, glucose, and leptin, which are opposite to the effects of human NASH [44, 45].”
High-fat emulsion-induced rat model of nonalcoholic steatohepatitis
Zou, Y., Li, J., Lu, C., Wang, J., Ge, J., Huang, Y., Zhang, L., & Wang, Y. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.03.021 · Cited by 239 · cited 1×
“In a study performed with Wistar rats using the same model of intragastric cannulation but with the administration of a trans-fat diet, the histopathological findings were more characteristic of themorphology found in humanNASH [51].”
Steatohepatitis Induced by Intragastric Overfeeding in Mice *
Deng, Q.-G., She, H., Cheng, J. H., French, S. W., Koop, D. R., Xiong, S., & Tsukamoto, H. (2005) · Hepatology · doi:10.1002/hep.20877 · Cited by 215 · cited 1×
“However, the histopathological analysis showed the development of mild hepatic steatosis [50].”
Jornayvaz, F. R., Jurczak, M. J., Lee, H.-Y., Birkenfeld, A. L., Frederick, D. W., Zhang, D., Zhang, X.-M., Samuel, V. T., & Shulman, G. I. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2010 · Cited by 211
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice
McCuskey, R. S., Ito, Y., Robertson, G. R., McCuskey, M. K., Perry, M., & Farrell, G. C. (2004) · Hepatology · doi:10.1002/hep.20302 · Cited by 210 · cited 1×
“The MCD diet also promotes higher expression of the intercellular adhesion-1 molecule (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and macrophage chemotactic protein-1 (MCP-1), which results in increased activity, migration, adhesion, and accumulation of neutrophils and macrophages in the liver [43].”
Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats
Xu, Z.-J., Fan, J.-G., Ding, X.-D., Qiao, L., & Wang, G.-L. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0815-3 · Cited by 196 · cited 1×
“This novel model may be potentially useful as a NASH model, although the main findings occurred only after week 24 [48].”
Experimental models of non-alcoholic fatty liver disease in rats
Kucera, O. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8364 · Cited by 195
Mitochondrial Proteins That Regulate Apoptosis and Necrosis Are Induced in Mouse Fatty Liver
Rashid, A., Wu, T.-C., Huang, C.-C., Chen, C.-H., Lin, H. Z., Yang, S. Q., Lee, F. Y., & Diehl, A. M. (1999) · Hepatology · doi:10.1002/hep.510290428 · Cited by 194
Modulation of hepatic steatosis by dietary fatty acids
Ferramosca, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1746 · Cited by 184 · cited 14×
“However, this model does not mimic the clinical and etiologic factors of NAFLD/NASH because the diet is forcibly administered (CF−).”
InfluentialFructose: A Key Factor in the Development of Metabolic Syndrome and Hypertension
Khitan, Z., & Kim, D. H. (2013) · Journal of Nutrition and Metabolism · doi:10.1155/2013/682673 · Cited by 180
Animal models for the study of hepatic fibrosis
Starkel, P., & Leclercq, I. A. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.004 · Cited by 178 · cited 1×
“Furthermore, it takes a long time for the symptomsof the high-fat diet to significantly develop [25, 49].”
Yu, J., Ip, E., dela Peña, A., Hou, J. Y., Sesha, J., Pera, N., Hall, P., Kirsch, R., Leclercq, I., & Farrell, G. C. (2006) · Hepatology · doi:10.1002/hep.21108 · Cited by 169
High fat diet feeding results in gender specific steatohepatitis and inflammasome activation
Ganz, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8525 · Cited by 164 · cited 1×
“Although these findings are consistent with NASH, in the female mice, hepatic inflammation and fibrosis were insipient [69].”
Murine models for pharmacological studies of the metabolic syndrome
Fellmann, L., do Nascimento, A. R., Tibiriçá, E. V., & Bousquet, P. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.004 · Cited by 163 · cited 2×
“Zucker rat hyperlipidemia is characterized by increased very low density lipoprotein (VLDL) and high density lipoprotein (HDL) without significant changes in low density lipoprotein (LDL) and reduced expression of the hepatic LDL-receptor [38].”
Otogawa, K., Kinoshita, K., Fujii, H., Sakabe, M., Shiga, R., Nakatani, K., Ikeda, K., Nakajima, Y., Ikura, Y., Ueda, M., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060441 · Cited by 162
Thapaliya, S., Wree, A., Povero, D., Inzaugarat, M. E., Berk, M., Dixon, L., Papouchado, B. G., & Feldstein, A. E. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3167-6 · Cited by 162
Lessons from animal models of NASH
Diehl, A. M. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.022 · Cited by 162 · cited 1×
“In addition, these animals have an altered metabolic profile and exhibit hyperglycemia, insulin resistance, hyperinsulinemia, and spontaneous development of fatty liver [34].”
Larter, C. Z., Yeh, M. M., Williams, J., Bell-Anderson, K. S., & Farrell, G. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.026 · Cited by 145 · cited 1×
“Other discrepancies in the metabolic profile of the MCD diet are reduced levels of insulin, glucose, and leptin, which are opposite to the effects of human NASH [44, 45].”
Jornayvaz, F. R., Samuel, V. T., & Shulman, G. I. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104726 · Cited by 126 · cited 14×
“However, this model does not mimic the clinical and etiologic factors of NAFLD/NASH because the diet is forcibly administered (CF−).”
InfluentialNonalcoholic fatty liver disease and cardiovascular risk
Misra, V. L., Khashab, M., & Chalasani, N. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0008-4 · Cited by 122
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression
Farrell, G. C., Larter, C. Z., Hou, J. Y., Zhang, R. H., Yeh, M. M., Williams, J., Dela Peňa, A., Francisco, R., Osvath, S. R., Brooling, J., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05785.x · Cited by 120 · cited 1×
“However, diverse evidences show that hepatocellular apoptosis is increased both in animal models [11–13] and in human NASH [14– 16].”
Wortham, M., He, L., Gyamfi, M. A., Copple, B. L., & Wan, Y. Y. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0193-7 · Cited by 101 · cited 1×
“When db/db mice are fed an MCD diet, they can develop significant liver fibrosis in contrast to ob/ob mice [36, 37].”
Lalanza, J. F., Caimari, A., del Bas, J. M., Torregrosa, D., Cigarroa, I., Pallàs, M., Capdevila, L., Arola, L., & Escorihuela, R. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085049 · Cited by 98 · cited 1×
“Young rats that received the cafeteria diet for 8 weeks developed metabolic syndrome along with obesity, higher hepatic weight, increased plasma levels of glucose, insulin and triglycerides, and insulin resistance [57].”
A collaborative database of inbred mouse strain characteristics
Grubb, S. C., Churchill, G. A., & Bogue, M. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth299 · Cited by 92
Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis
Ramalho, R. M., Cortez-Pinto, H., Castro, R. E., Sol??, S., Costa, A., Moura, M. C., Camilo, M. E., & Rodrigues, C. M. P. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200601000-00005 · Cited by 89 · cited 1×
“However, diverse evidences show that hepatocellular apoptosis is increased both in animal models [11–13] and in human NASH [14– 16].”
Review article: steatosis, the metabolic syndrome and cancer
Bugianesi, E. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02594.x · Cited by 80 · cited 1×
“Because of the high prevalence of NAFLD in the obese population, NAFLD can be considered one of themanifestations of metabolic syndrome including central obesity, type II diabetes mellitus, hypertension, hyperglycemia, and hyperlipidemia [2].”
Nakayama, H., Otabe, S., Ueno, T., Hirota, N., Yuan, X., Fukutani, T., Hashinaga, T., Wada, N., & Yamada, K. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.004 · Cited by 79
Carillon, J., Romain, C., Bardy, G., Fouret, G., Feillet‐Coudray, C., Gaillet, S., Lacan, D., Cristol, J., & Rouanet, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.022 · Cited by 73 · cited 1×
“Although this diet induced insulin resistance and increased liver oxidative stress, proinflammatory mediators such as TNF-α, IL-6, and NF-κB were not enhanced [58].”
Vendramini, V., Cedenho, A. P., Miraglia, S. M., & Spaine, D. M. (2013) · Reproductive Sciences · doi:10.1177/1933719113493511 · Cited by 69
Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease
Basaranoglu, M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i18.2223 · Cited by 65
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
Machado, M. V., & Cortez-Pinto, H. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.16 · Cited by 50 · cited 1×
“Both JNK and p38 MAP kinase are involved inmechanisms of apoptosis [17, 18].”
A Human-Type Nonalcoholic Steatohepatitis Model with Advanced Fibrosis in Rabbits
Ogawa, T., Fujii, H., Yoshizato, K., & Kawada, N. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090895 · Cited by 48
Evaluation of Liver Fatty Acid Oxidation in the Leptin-Deficient Obese Mouse
Brix, A. E., Elgavish, A., Nagy, T. R., Gower, B. A., Rhead, W. J., & Wood, P. A. (2002) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2002.3298 · Cited by 41 · cited 14×
“However, this model does not mimic the clinical and etiologic factors of NAFLD/NASH because the diet is forcibly administered (CF−).”
InfluentialBrunt, E. M., Kleiner, D. E., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Torbenson, M. S., & Yeh, M. (2011) · Hepatology · doi:10.1002/hep.24347 · Cited by 35
Cheng, Q., Li, N., Chen, M., Zheng, J., Qian, Z., Wang, X., Huang, C., Xu, S., & Shi, G. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2823-6 · Cited by 35
A rabbit model of pediatric nonalcoholic steatohepatitis: The role of adiponectin
Fu, J., Fang, Y., Liang, L., Wang, C., Hong, F., & Dong, G. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.912 · Cited by 35
In Vitro and In Vivo Protection of Stellate Cells from Apoptosis by Leptin
Qamar, A., Sheikh, S. Z., Masud, A. J., Jhandier, M. N., Inayat, I., Hakim, W., & Mehal, W. Z. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9244-8 · Cited by 34 · cited 1×
“Leptin is also involved in the modulation of fibrogenesis and cell death [31–33].”
Editorial: Exploring Lipid-related Treatment Options for the Treatment of NASH
Rizzo, M., Montalto, G., & Vinciguerra, M. (2014) · Current Vascular Pharmacology · doi:10.2174/157016111205140926155515 · Cited by 6
Cited by
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Ipsen, D. H., Lykkesfeldt, J., & Tveden-Nyborg, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2860-6 · Cited by 1,471
“Noticeably, a major limitation of the current models utilizing Western diets, not employing micronutrient deficiency or abnormally high amounts of cholesterol, is the absence of progressive, advanced hepatic fibrosis [129].”
BackgroundNonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044224 · Cited by 611
“Vital insights into the pathogenesis and underlying mechanisms of NAFLD have been gained from the study of existing animal models; detailed discussion is outside the scope of this article and is reviewed elsewhere (87) and summarized in Table 1.”
BackgroundA diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
Asgharpour, A., Cazanave, S. C., Pacana, T., Seneshaw, M., Vincent, R., Banini, B. A., Kumar, D. P., Daita, K., Min, H.-K., Mirshahi, F., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.005 · Cited by 538
“While a large number of models have been described, they have several limitations [2] (Supplementary Table 1).”
BackgroundChastin, S. F. M., De Craemer, M., De Cocker, K., Powell, L., Van Cauwenberg, J., Dall, P., Hamer, M., & Stamatakis, E. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-097563 · Cited by 465
Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
Van Herck, M., Vonghia, L., & Francque, S. (2017) · Nutrients · doi:10.3390/nu9101072 · Cited by 392
“It is generally accepted that the genetic mutation alone is not sufficient for the development of NASH and a second stimulus is needed in the form of a chemical challenge (including lipopolysaccharide, CCL4 and TAA administration) or dietary measures (including MCD diet and HFD) [28,62].”
BackgroundInfluential
Metadata
- Authors
- Sanches, S. C. L., Ramalho, L. N. Z., Augusto, M. J., da Silva, D. M., & Ramalho, F. S.
- Affiliations
- Universidade de São Paulo (BR)
- Department of Pathology, School of Medicine of Ribeirão Preto, University of São Paulo, Avenida Bandeirantes 3900, Monte Alegre, 14049-900 Ribeirão Preto, SP, Brazil
- Corresponding author
- Ramalho, Fernando Silva
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4433658
- OpenAlex
- W1969807612
- Cited by
- 174
- References
- 74
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 10 · 2023: 8 · 2022: 15 · 2021: 16 · 2020: 21 · 2019: 30 · 2018: 24 · 2017: 19 · 2016: 24 · 2015: 2
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (160028/2012-4)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, animal models, hepatic steatosis, liver fibrosis, ob/ob mice, db/db mice, Zucker rats, methionine-choline-deficient diet, high-fat diet, high-fructose diet, cafeteria diet, high-cholesterol diet, genetic models, nutritional models
- MeSH terms
- Animals, Disease Models, Animal, Humans, Liver Cirrhosis, Disease Progression, Mice, Rats, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.